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ABSTRACT 
Influenza infection in late trimester associated with complications is attributable risk factors for critical illness among pregnant women. We have 
analyzed the medical records of four pregnant women retrospectively who were admitted in a medical intensive care unit of tertiary care center 
with influenza-like symptoms of breathlessness, fever, headache, myalgia and cough. Their mean age was 26.5 (19-30). They were confirmed to 
have H1N1infection by real-time reverse transcriptase polymerase chain reaction assay. Chest x-ray of all patients showed abnormalities like 
pulmonary edema and suggestive of acute respiratory distress syndrome. Arterial blood gas analysis of all four patients shown severe hypoxia and 
all of them was mechanically ventilated. Oseltemivir was started for all four from the day of admission. Pipracillin-tazobactum combination along 
with other antibiotics was given as prophylaxis and treatment of different infections. Midazolam and morphine were given together to reduce the 
restlessness and ventilator-associated distress. Furosemide was given to all for breathing problems and pulmonary edema. Despite of all the 
management provided none of the patients survived due to the progression of H1N1 into septic shock and multiple organs dysfunction syndromes.  
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INTRODUCTION 
World Health Organization (WHO) has declared that the new strain 
of virus is more likely to cause infection in pregnant women. Hence 
Influenza A-H1N1 (Hemagglutinin-H-neuroaminidase-N) infection is 
a severe cause of illness and mortality in pregnant women. 
Admission of pregnant women with H1N1 infection and the 
associated mortality is increased when compared with non-pregnant 
women [1]; mostly death occurs in the late trimester of pregnant 
women. The real-time reverse transcriptase-polymerase chain 
reaction (RT-PCR) technique is widely used to confirm H1N1 
infection. The increased risk of H1N1infection in pregnant women is 
due to the occurrence of several physiological, mechanical and 
hormonal alterations. Cardiovascular and respiratory systems 
changes (increased heart rate, stroke volume, oxygen consumption 
and decreased lung capacity) are other factors associated with 
mortality in pregnant women [2-4]. Here we are reporting 4 cases 
diagnosed with HIN1 in the third trimester of pregnancy with 
clinical characteristics, risk factors and management. Permission 
from institutional ethical committee (IEC) was taken for the same. 
The main reason came out with the high mortality rate in pregnant 
women is the delayed treatment with antiviral therapy, severity of 
the symptoms, other associated infections and resistant of antibiotic 
therapy [5]. According to Centers for Disease Control and Prevention 
(CDC) recommendations, antiviral therapy should initiate 
immediately if the pregnant woman in suspected to have H1N1 
infection. The patient started on antivirals after 48 h have 4 times 
more risk of intensive care unit (ICU) admission or fatal outcomes. 
Co-morbidities also worsen the outcome. This case series enlighten 
the fatal prognosis of H1N1 in pregnant women in a late trimester.  
Case presentation 
Case 1 
A 30 y old pregnant woman admitted to a tertiary care hospital with 
chief complaints of pedal edema, fever, breathlessness when she was 
primigravida at 25 w. The patient had influenza type symptoms and 
yet on oseltemivir 150 mg twice daily for 2 d from the local hospital 
with no other co-morbidities. Her blood pressure was 160/100 
mmHg, SPO2 of 72 % on room air and started on non-invasive 
ventilation (NIV) with FiO2 = 100 %. Her arterial blood gas (ABG) 
analysis showed a predominant decrease in pH (7.052), PaO2 (83.2 
mmHg) and increase in the PaCO2 (50.3 mmHg). On admission her 
blood reports showed serum creatinine (5.9 mg/dl), hemoglobin 10 
g/l, total leucocytes count 10,700 cells/mm3 and absolute neutrophil 
count 36,960/mm3. Urine analysis showed high protein (15 mg/dl), 
the presence of uric acid crystals and WBC (12-15 cells/ml). To 
confirm the H1N1 infection patient’s throat swab was taken which 
came out to be positive by RT-PCR technique. She has started on 
azithromycin 400 mg daily for 5 d, tazobactam and piperacillin 4.5 g 
twice daily for a week and continuation of oseltemivir 150 mg twice 
daily with methylprednisolone 80 mg at every 8 h as supportive 
care. As the patient was on ventilation support; midazolam IV 
infusion 4 mg/h was given for 5 d, for ventilator-associated stress 
and restlessness. Furosemide 20 mg twice daily given for 2 d, 
intravenously as the patient had pedal edema.  
Erythropoietin 1 ampoule (4000 IU) daily given for 6 d, as patient’s 
hemoglobin, was low. Her condition deteriorated during the 
management, and she developed acute respiratory distress 
syndrome (ARDS) and intrauterine sepsis along with H1N1 
infection. On 8th day of admission her condition worsened which 
leads to excessive dropping in blood pressure (60/40 mmHg) due to 
which dopamine 20 µg/kg/min was administered. The patient 
developed multiple organ dysfunction syndromes (MODS) on the 
10th day and succumbed to cardiac arrest.  
Case 2 
A 19 y old pregnant woman was admitted with chief complaints of 
fever and cough for 1 w, breathlessness and sore throat for 4 d. She 
was primigravida at 34 w. Patient’s medical history revealed that 
she had developed bilateral pneumonia/ARDS primarily and was on 
azithromycin from a local hospital. On the 2nd day of admission, 
lower (uterine) segment caesarean section (LSCS) was done with the 
delivery of twins; both babies were fine and doing well. Her SPO2 is 
82 % on room air and 97 % on NIV 60 % venture. She had 
tachypnea; harsh vesicular breath sounds heard in all areas with 
crepts. H1N1 was confirmed by PCR technique from patient’s throat 
swab and chest x-ray showed homogenous opacity suggested of 
ARDS. Her ABG analysis showed abnormal PaCO2 (19.1 mmHg), PaO2 
(68.4 mmHg), SO2 (93.2 %) with low potassium of 2.5 meq/l. Blood 
reports showed low hemoglobin 9.1 g/dl, total leukocyte count 
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(TLC) 20,800 cells/mm3, ESR 94 mm/h with normal liver function 
test and urine analysis showed no abnormalities. She was started on 
piperacillin and tazobactam in combination 4.5 g daily intravenously 
for 7 d, oseltemivir 75 mg twice daily for continuous and powder 
potassium chloride was given the first day only as the potassium 
level was low (3.2 mmol/l). Furosemide 20 mg IV was given on the 
first day; again started on the 5th day and continued till 11th day. Her 
condition worsened on 7th day so she was shifted to mechanical 
ventilation and Midazolam infusion 1 ml/h started for ventilator-
associated stress. On that day ABG analysis showed pH 7.58, PaO2 
(56 mmHg), PaCO2 (28 mmHg) and HCO3 (24 meq/l). On 7th day 
patient also developed sepsis and piperacillin-tazobactam changed 
to netilmicin 150 mg daily and meropenem 1 g for every 8 h 
intravenously to continue. One packed cell pint was transfused on 
the 11th day for low hemoglobin and supported by inotropes and 
morphine for her deteriorated condition. Patient succumbed to 
bradycardia and septic shock on the same day. 
Case 3 
A 30 y old female admitted to a tertiary care hospital with chief 
complaints of a cough, fever, breathlessness, vomiting and 39 w of 
gestation. Patient’s medical history revealed that she had upper 
respiratory tract infection outside before 1 w with no medication 
history. Her ABG analysis showed pH 7.376, PaCO2 24.2 mmHg and 
PaO2 74.8 mmHg. On admission, her PaO2 was 95 % and SPO2 was 97 
% on 60 % venturi, she also presented crepts. Other biochemical and 
hematological reports were normal on admission. The patient was 
confirmed to have H1N1 by RT-PCR technique. She was started on 
medication piperacillin-tazobactam in combination 4.5 g daily 
intravenously, oseltemivir 150 mg once daily and 5 % dextrose 
solution at 60 ml/h with other supportive settings.  
Tramadol 50 mg intramuscular was given thrice daily for 2 d 
followed by propofol 20 mg IV stat on 3rd day. Midazolam 20 mg and 
morphine 30 mg daily intravenously were given the 4th day to 
continue. By 5th day clinician started meropenem 1 g IV at every 8 h 
and teicoplanin 400 mg IV twice daily and stopped piperacillin and 
tazobactam in combination because no symptomatic improvement 
noticed. On 7th day of admission, the patient has developed 
metabolic acidosis (pH 7.28, PaCO2 87.0 mmHg, PaO2 47.2 mmHg 
and SO2 74 %) and ventilator-associated pneumonia; chest x-ray 
showed pulmonary edema and homogenous opacity which 
suggested having ARDS. Furosemide 20 mg IV was given for one day 
for pulmonary edema. On 9th day total leucocyte count was seen high 
as 23,900 cells/mm3 so blood culture was sent for microbiological 
testing. After 24 h blood culture report shown multidrug-resistant 
acinobactor and antibiotics (meropenem and teicoplanin) changed 
to colistimethate (colistin) 1 million IU at every 8 h continue. Same 
day patient showed symptoms of deep vein thrombosis hence 
enoxaperin 0.4 ml (40 mg) daily was started. On 14th day, she 
developed the symptoms of restlessness, shallow breathing and 
succumbed to respiratory acidosis and septic shock. 
Case 4 
A 27 y old female was admitted with chief complaints of a cough for 
2 w, breathlessness and fever for 5 d and she was primigravida at 26 
w. The patient had nil medical history. On admission, she had 
tachypnea, bronchial breathing in the left intra-scapular area, 
reduced breath sounds in the right intra-scapular and intra axillary 
area with positive crepts. Her SPO2 was 70 % on 60 % venturi and 
she was severely hypoxic with grade 3 diastolic dysfunction. ABG 
analysis showed pH 7.26, PaCO2 47.2 mmHg, PaO2 48.8 mmHg and 
SO2 was 77 %. H1N1influenza has confirmed from her throat swab 
sample by RT-PCR technique and chest x-ray showed fluffy bilateral 
shadows sparing the left upper zone. Her biochemical, hematological 
reports were normal except high TLC; 11200 cells/mm3 and low 
hemoglobin 11.8 g/dl. She was started on azithromycin 500 mg IV, 
nebulizer salbutamol-ipratropium bromide combination at every 8 
h, injection piperacillin-tazobactam 4.5 g intravenously and 
oseltemivir 150 mg twice daily with other supportive care as 5 % 
dextrose solution 50 ml/h. The patient condition was worsening so 
azithromycin, nebulizer salbutamol-ipratropium bromide and 
piperacillin-tazobactam were stopped and she switched to 
meropenem 1g IV daily, clarithromycin 500 mg twice daily oral and 
hydrocortisone 100 mg IV daily intravenously for 2 d followed by 
same for continue. Morphine 30 mg daily has started with 
midazolam 20 mg daily for sedative effect as the patient was on 
mechanical ventilation from admission. On 3rd day patient had 
unusual vaginal bleeding so UFH 5000 U was given subcutaneously 
continue. On 5th day she developed ARDS and biochemical 
investigations showed abnormality; blood urea 49 mg/dl, serum 
creatinine 2.8 mg/dl, sodium 155 meq/l and potassium 5.6 meq/l. 
ABG analysis showed pH 7.01, PaCO2 78.0 mmHg, PaO2 46.8 mmHg 
and SO2 82 %, these all suggestive of respiratory acidosis. 
Ventilation settings were changed according to patient need. On 5th 
day condition worsened with blood urea 124 mg/dl, serum 
creatinine 4.7 mg/dl, sodium 156 meq/l and potassium 5.7 meq/l 
and ABG analysis showed pH 7.36, PaCO2 44.0 mmHg, PaO2 45.2 
mmHg and SO2 80 %. During the course of treatment, a patient 
condition exacerbated on 6th day morning and succumbed to MODS 
and septic shock.  
DISCUSSION  
A number of studies have been carried out related to mortality and 
morbidity in female patients with H1N1 infection, but there is no 
sufficient data that proves the association of mortality and 
pregnancy clearly. According to CDC in 2009 pandemic influenza the 
rate of hospitalization was 4 times higher in pregnant women than 
the rest of population. Hereby we have presented the 4 female 
patients in their late trimesters with high-risk factors associated 
with mortality. In view of the discussion, we found that 
complications in H1N1 infection in pregnant females [table 1] are 
more towards the mortality. The need of immediate hospitalization 
in pregnant females is increased due to H1N1 infection and its 
complications. 
 
Table 1: Detailed course of all 4 cases of H1N1 infection, succumbed in late trimesters. 
 Case 1 Case 2 Case 3 Case 4 
Age 30 y 19 y 30 y 27 y 
Pregnancy status 25 w 34 w 39 w 26 w 
Medical history Nil Pneumonia/ARDS URTI Nil 
SPO2 level on Admission 72 % on room air 82 % on room air 97 % on 60 % venturi 70 % on 60 % venturi 
Intubated/Ventilation support Yes Yes Yes Yes 
Hemoglobin 10 g/dl 9.1 g/dl 12.6 g/dl 11.8 g/dl 
Total leucocytes count 10700 cells/mm3 20800 cells/mm3 8800 cells/mm3 11,200 cells/mm3 
Duration of stay 10 d 11 d 14 d 6 d 
Antibiotic Resistance No Yes Yes Yes 










Septic shock  
Outcome Expired Expired Expired Expired 
(URTI, upper respiratory tract infection; ARDS, acute respiratory distress syndrome; MODS, multiple organ dysfunction syndrome; SPO2, saturation 
of oxygen) 
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Various physiological, mechanical and hormonal alterations are the 
leading cause of severe outcomes and high mortality rates in 
pregnant women. Heart rate, stroke volume, oxygen consumption 
and decrease lung capacity are the changes in the cardiovascular and 
respiratory system during pregnancy. Immunological changes in 
pregnancy showed a shift from cell-mediated immunity to hormonal 
immunity that also increased the risk of getting an infection and fatal 
outcomes [2-5]. Pregnant females have similar influenza-like 
symptoms such as a cough, sore throat, fever and breathlessness. 
Among these females with similar symptoms few of them rapidly 
deteriorate to ARDS and various other complications hence becomes 
critical and shift to mechanical ventilation. This generally occurs in 
the later phase of pregnancy due to shift from the cell-mediated 
immunity [6]. 
We have assessed the 4 cases during 2013 and 2014 with age 
range of 19-30 y. The RT-PCR technique is used to confirm the 
H1N1influenza infection. All 4 were mechanically ventilated on 
the basis of disease severity. As per the WHO guidelines and 
various studies were done for sepsis-induced ARDS are brought 
into consideration for the management therapy [7]. Females 
admitted in the late phase of pregnancy are at major risk so the 
pre-term delivery can reduce the risk of mortality for baby and 
mother both and can increase the survival chances. Catanzarite 
and Willms 1997 reviewed 83 similar cases which showed 
timing delivery is necessary for sepsis-associated ARDS patients. 
As soon as the delivery is extubated the condition improves 
dramatically within 24 h. Pre-term delivery is basically 
performed to reduce the risk of mortality and to increase the 
therapeutic option for the mother [1, 8]. 
In the above-studied cases only 1 female underwent delivery and 
gave birth to normal and healthy twins, but other 3 didn’t have a 
suitable condition to undergo delivery. The cause of death in the 
female who underwent caesarian is sudden bradycardia and 
multiple organ dysfunction syndromes. In all four patients, 
oseltemivir is started as soon as they got confirmed for 
H1N1infection. They all started with various antibiotic 
combinations as prophylaxis or treatment for suspected and 
confirmed infections. Based on their severity and low SPO2 
levels, they were put on ventilation support and were started 
with morphine and midazolam together to reduce the 
mechanical distress and restlessness. They were also given with 
diuretics due to pulmonary edema and breathing problems. Due 
to the advancement of the clinical condition females developed 
resistance to antibiotics which deteriorate their condition 
further and they developed ARDS and multiple organ failures [8, 
9]. There is not much study or literature available on pregnant 
females with H1N1, ARDS, MODS and not responding on 
mechanical ventilation. Such female has to go under proper 
guidelines of management with their timely onset of action. The 
mortality can be reduced if the adjuvant therapy would be 
initiated timely [10]. 
It is really important to focus on the emergency requirements/needs 
in such critical situations, or cases have a chance to get critical. The 
various factors should remain in focus such as early detection of 
diseases, commencement of antiviral therapy, resistance towards 
antibiotics, the hypoxic condition of the patients along with fetus 
delivery in infected pregnant females.  
CONCLUSION  
The study showed that pregnant women are at more risk when 
compared with the normal population. They are more prone to get 
infected and hence high mortality rate. In the study, we found out 
various mortality factors that lead to death in pregnant females. We 
found out that pregnant females in their late trimester develop 
ARDS, sepsis, MODS those shifts the risk towards a fatal outcome. 
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